ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 5 Trends To Watch This Year

  Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

• Our Unified Platform Serves As eSource For COVID Treatment Trial

  Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

• Revolutionizing Clinical Trial Feasibility

  Transform feasibility into a continuous, data-driven process, that helps sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster.

• Re-Consent In Clinical Trials: Streamlining With eConsent

  Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.

• Driving Successful Obesity Drug Development With GLP-1 Agonists

  GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.

• Removing Translation Bottlenecks With AI

  See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.

• 5 Features to Look for in Your Next eTMF

  Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.

• EDC System Provides Flexibility, Scalability For Mid-Study Changes

  Discover the importance of using a robust, scalable, and flexible EDC solution that handles mid-study changes for even the most complex clinical trials.

• Position Your DHT Innovation For Success

  Explore three factors that significantly influence the success of clinical trials incorporating digital health technology.

• Do We Still Need Patients In Tomorrow's Trials?

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.